ADAPTIVE BIOTECHNOLOGIES (ADPT) Stock Earnings Estimates
NASDAQ:ADPT • US00650F1093
15.555 USD
+0.02 (+0.1%)
Last: Feb 13, 2026, 09:36 AM
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 170.276M -8.11% | 178.957M 5.10% | 276.976M 54.77% | 271.41M -2.01% | 333.96M 23.05% | 397.94M 19.16% | 552.02M 38.72% | 654.33M 18.53% | |
| EBITDA YoY % growth | -179.375M -0.94% | -136.088M 24.13% | N/A 90.13% | -36.454M -171.40% | 17.176M 147.12% | 87.72M 410.71% | 49.368M -43.72% | 71.4M 44.63% | |
| EBIT YoY % growth | -201.606M -1.51% | -155.344M 22.95% | -57.123M 63.23% | -90.497M -58.42% | -55.983M 38.14% | -22.406M 59.98% | 15.504M 169.20% | -100.00% | |
| Operating Margin | -118.40% | -86.81% | -20.62% | -33.34% | -16.76% | -5.63% | 2.81% | N/A | |
| EPS YoY % growth | -1.38 2.13% | -1.09 21.01% | -0.40 63.30% | -0.60 -51.09% | -0.38 36.35% | -0.15 62.00% | -0.15 -4.68% | -0.01 93.33% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.16 17.76% | -0.15 10.75% | -0.15 -342.25% | -0.13 -43.08% | -0.13 22.48% | -0.07 56.30% | -0.10 33.33% | -0.07 48.51% | -0.05 60.00% | 0.01 115.38% | -0.08 15.79% |
| Revenue Q2Q % growth | 61.445M 17.17% | 66.468M 12.89% | 70.264M -25.23% | 74.239M 3.57% | 71.043M 15.62% | 84.915M 27.75% | 85.272M 21.36% | 90.066M 21.32% | 92.004M 29.50% | 104.04M 22.52% | 99.654M 16.87% |
| EBITDA Q2Q % growth | -8.328M 66.52% | -5.059M 67.99% | 3.998M -83.29% | 2.137M 128.11% | -2.04M 75.51% | 10.261M 302.82% | 14.015M 250.55% | 19.237M 800.19% | N/A | N/A | N/A |
| EBIT Q2Q % growth | -25.013M 15.51% | -22.132M 11.60% | -22.097M -314.74% | -20.066M -57.10% | -20.212M 19.20% | -10.053M 54.58% | -14.578M 34.03% | -9.98M 50.27% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | -0.09 60.87% | -0.18 | 0.09 | 51.32% |
| Q3 2025 Q2Q % growth | 0.06 127.27% | -0.15 | 0.21 | 140.22% |
| Q2 2025 Q2Q % growth | -0.17 45.16% | -0.24 | 0.07 | 30.19% |
| Q1 2025 Q2Q % growth | -0.20 39.39% | -0.30 | 0.10 | 32.96% |
| Q4 2024 Q2Q % growth | -0.23 23.33% | -0.26 | 0.03 | 12.00% |
| Q3 2024 Q2Q % growth | -0.22 37.14% | -0.29 | 0.07 | 24.98% |
| Q2 2024 Q2Q % growth | -0.31 6.06% | -0.34 | 0.03 | 8.94% |
| Q1 2024 Q2Q % growth | -0.33 17.50% | -0.35 | 0.02 | 5.24% |
| Q4 2023 Q2Q % growth | -0.30 -7.14% | -0.34 | 0.04 | 11.21% |
| Q3 2023 Q2Q % growth | -0.35 -9.37% | -0.35 | 0.00 | -1.25% |
| Q2 2023 Q2Q % growth | -0.33 10.81% | -0.35 | 0.02 | 6.66% |
| Q1 2023 Q2Q % growth | -0.40 9.09% | -0.38 | -0.02 | -4.08% |
| Q4 2022 Q2Q % growth | -0.28 34.88% | -0.35 | 0.07 | 20.75% |
| Q3 2022 Q2Q % growth | -0.32 20.00% | -0.38 | 0.06 | 16.56% |
| Q2 2022 Q2Q % growth | -0.37 -5.71% | -0.44 | 0.07 | 15.64% |
| Q1 2022 Q2Q % growth | -0.44 -51.72% | -0.47 | 0.03 | 5.93% |
| Q4 2021 Q2Q % growth | -0.43 -30.30% | -0.46 | 0.03 | 6.61% |
| Q3 2021 Q2Q % growth | -0.40 -48.15% | -0.43 | 0.03 | 6.91% |
| Q2 2021 Q2Q % growth | -0.35 -34.62% | -0.44 | 0.09 | 19.67% |
| Q1 2021 Q2Q % growth | -0.29 -16.00% | -0.42 | 0.13 | 30.41% |
| Q4 2020 Q2Q % growth | -0.33 | -0.30 | -0.03 | -10.47% |
| Q3 2020 Q2Q % growth | -0.27 | -0.29 | 0.02 | 6.89% |
| Q2 2020 Q2Q % growth | -0.26 | -0.29 | 0.03 | 10.56% |
| Q1 2020 Q2Q % growth | -0.25 | -0.21 | -0.04 | -19.85% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2025 Q2Q % growth | 71.681M 51.04% | 60.579M | 11.102M | 18.33% |
| Q3 2025 Q2Q % growth | 93.973M 102.38% | 65.936M | 28.037M | 42.52% |
| Q2 2025 Q2Q % growth | 58.879M 36.33% | 50.388M | 8.491M | 16.85% |
| Q1 2025 Q2Q % growth | 52.443M 25.24% | 43.532M | 8.911M | 20.47% |
| Q4 2024 Q2Q % growth | 47.459M 3.66% | 46.955M | 504K | 1.07% |
| Q3 2024 Q2Q % growth | 46.435M 22.46% | 41.012M | 5.423M | 13.22% |
| Q2 2024 Q2Q % growth | 43.19M -11.72% | 39.438M | 3.752M | 9.51% |
| Q1 2024 Q2Q % growth | 41.873M 11.23% | 39.56M | 2.313M | 5.85% |
| Q4 2023 Q2Q % growth | 45.784M -17.06% | 49.427M | -3.643M | -7.37% |
| Q3 2023 Q2Q % growth | 37.919M -20.72% | 43.822M | -5.903M | -13.47% |
| Q2 2023 Q2Q % growth | 48.926M 12.06% | 45.785M | 3.141M | 6.86% |
| Q1 2023 Q2Q % growth | 37.647M -2.52% | 37.547M | 100K | 0.27% |
| Q4 2022 Q2Q % growth | 55.2M 45.53% | 55.8M | -600K | -1.08% |
| Q3 2022 Q2Q % growth | 47.83M 21.18% | 48.991M | -1.161M | -2.37% |
| Q2 2022 Q2Q % growth | 43.66M 13.37% | 43.004M | 656K | 1.53% |
| Q1 2022 Q2Q % growth | 38.62M 0.47% | 38.464M | 156K | 0.41% |
| Q4 2021 Q2Q % growth | 37.93M 25.64% | 37.437M | 493K | 1.32% |
| Q3 2021 Q2Q % growth | 39.47M 50.08% | 37.368M | 2.102M | 5.63% |
| Q2 2021 Q2Q % growth | 38.51M 83.47% | 31.887M | 6.623M | 20.77% |
| Q1 2021 Q2Q % growth | 38.44M 83.84% | 28.302M | 10.138M | 35.82% |
| Q4 2020 Q2Q % growth | 30.19M | 27.44M | 2.75M | 10.02% |
| Q3 2020 Q2Q % growth | 26.3M | 24.055M | 2.245M | 9.33% |
| Q2 2020 Q2Q % growth | 20.99M | 19.176M | 1.814M | 9.46% |
| Q1 2020 Q2Q % growth | 20.91M | 21.958M | -1.048M | -4.77% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0.68% | 0.68% | 0% | 27.99% |
| Revenue | 0.17% | 0% | 0.03% | 10.58% |